PENG YUAN
Unknown · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1 Solid Tumor Cancer, Metastatic Solid Tumors, Locally Advanced | — | 2025-07-30 |
| Completed | Anlotinib in Metastatic HER2 Negative Breast Cancer Breast Neoplasm, Antineoplastic Agents, Anlotinib | Phase 2 | 2018-07-12 |
| Unknown | Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma Soft Tissue Sarcoma | Phase 2 | 2012-11-01 |